Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

T cell receptors, immunoregulation, and autoimmunity.

S W Brostoff1, M D Howell

  • 1Immune Response Corporation, Carlsbad, California 92008.

Clinical Immunology and Immunopathology
|January 1, 1992
PubMed
Summary

T cell receptor (TCR) peptide vaccines show promise for treating autoimmune diseases in humans. Further research may lead to new therapies for various T cell-mediated conditions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Identification of unique proteomic signatures in allergic and non-allergic skin disease.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

How the discovery of ISS-N1 led to the first medical therapy for spinal muscular atrophy.

Gene therapy·2017
Same author

Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.

European journal of neurology·2015
Same author

Past, present, and future for biologic intervention in atopic dermatitis.

Allergy·2015
Same author

Lectican proteoglycans, their cleaving metalloproteinases, and plasticity in the central nervous system extracellular microenvironment.

Neuroscience·2012
Same author

The association of lactate and vasopressor need for mortality prediction in survivors of cardiac arrest.

Minerva anestesiologica·2011

Area of Science:

  • Immunology
  • Vaccinology
  • Autoimmune Disease Research

Background:

  • T cell receptor (TCR) peptide vaccines are effective in animal models for autoimmune disease.
  • Human applications of TCR peptide vaccines are under investigation.
  • TCR peptides offer a potential therapeutic strategy for T cell-mediated pathologies.

Purpose of the Study:

  • To explore the potential of TCR peptide vaccines for treating human autoimmune diseases.
  • To assess the feasibility of developing TCR peptide immunization as a therapeutic option.
  • To evaluate the long-term prospects of TCR peptide technology in managing T cell immunity.

Main Methods:

  • Utilizing TCR peptide vaccination strategies.
  • Investigating immune responses in preclinical models.
  • Exploring therapeutic applications in autoimmune and lymphoproliferative disorders.

Main Results:

  • TCR peptide vaccines demonstrate efficacy in preventing and treating autoimmune disease in animal models.
  • Preliminary data suggest optimism for human autoimmune disease treatment.
  • The technology holds potential for manipulating T cell immunity.

Conclusions:

  • TCR peptide vaccines represent a promising avenue for autoimmune disease therapy.
  • Further development could lead to treatments for a range of T cell-mediated conditions.
  • This approach may enable targeted manipulation of T cell populations for therapeutic benefit.

Related Experiment Videos